ARCHIVES

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

This article is from The Cancer Letter archive.

Vol. 21 No. 40 | October 20, 1995

Download PDF Visit The Full Archive

Related Articles

Dingell To Challenge NCI, NSABP Handling Of Fraud, Delays

April 8, 1994

Zometa Can Reduce Risk Of Skeletal-Related Events

August 26, 2011

NSABP Researcher Committed Misconduct, NIH Investigation Finds

March 18, 1994

NCI Facing Extended Tie Under Acting Director – Maybe

August 19, 1988

Budget Projections for 1978 Offer Clues On Research NCI Hopes To Fund

June 18, 1976

NIAID Names Tramont Director, Division Of AIDS.

July 20, 2001